1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
5De Gramont A, Figer A, Seymour M, et al. Leucovofin and fluorouracil with or without oxaliplatin as first-line treatment in advanced coloreetal cancer[ JJ. J Clin Oncol,2000,18 (16) :2938-2947.
6Louvet C, Andre T, Tigaud JM, et al. Phase Ⅱ study of oxaliplatin, fluoreuracil, and folinic acid in locally advanced or metastatic gastric cancer patients [ J ]. J Clin Oncol,2002,20 (23) :4543-4548.
7Ajani J A. Treatment of patients with upper gastrointestinal carcinemas[J]. Semin Oncol, 1997,24(Suppl 19) : 1972-1976.
8Wohrer S S, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer[J]. Ann Oncol, 2004, 15(11): 1585 -1595.
9Minsky BD.Adjuvant therapy for rectal cancer:the transatlantic view[J].Colorectal Dis,2003,5(5):416.
10Yoshida H,Ishiko O,SumiT,et a.l Survivin,bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell and serous-type ovarian carcinomas[J].Int J Oncol,2001,19(3):537.
